Posts

Gilead and Merck Release Key HIV Data

on

Merck’s Lipfendra becomes world’s first oral PCSK9 treatment approved by FDA

on

Merck touts Keytruda front-line win in endometrial cancer subtype, marking a PD-1 first

on

Kelun's sac-TMT scores win in first-line PD-L1-negative NSCLC population missing from Merck's KEYTRUDA phase 3 program

on

AstraZeneca pays Sino $200M upfront, up to $1.9B for COPD challenger to Merck’s Ohtuvayre

on

Merck Posts Encouraging Phase 3 Ulcerative Colitis Data But Roche Challenge Looms

on

Merck’s IBD Drug from $10.8B Prometheus Deal Claims First Phase 3 Win

on

Portal Biotechnologies raises $9M for cell engineering tech that’s attracted Merck & Co., AbbVie

on

Friday Five: Verges neuro drug-to-data pivot

on

Merck adds to biopharma’s AI agenda with up to $510M+ Protillion pact

on

ASCO: Merck, Kelun's sac-TMT ADC combo beats Keytruda by 65% on progression in first-line lung cancer

on

Roche's Tecentriq, Pfizer/Astellas' Padcev and Merck's Keytruda in Bladder Cancer Battle: Recent Updates

on

Merck's ADC sac‑TMT gets its first global Phase 3 win ahead of schedule

on

Merck & Co.'s Keytruda Posts $8B in Q1 2026 as Qlex Picks Up Steam

on

Recent Pharma News: Novo Nordisk's Oral Semaglutide for Kids, Altimmune $225M Offering, Merck-Google Cloud Partnership

on

Merck's AI Partnership with Google Cloud to Reimagine Commercial Engagement with HCPs

on

FDA Approves Merck's Once-Daily HIV Pill Idvynso (Doravirine/Islatravir)

on

Merck Litespark Shocker: Welireg Triplet Fails in First-Line Kidney Cancer

on

Revolution Medicines Buyout Valuation Post-Phase 3: Talks Collapse at $30B

on

European Commission Approves Merck's ENFLONSIA (clesrovimab) for RSV Prevention in Infants

on